Dual influence of spontaneous hypertension on membrane properties and ATP production in heart and kidney mitochondria in rat: Effect of captopril and nifedipine, adaptation and dysadaptation

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 9, 2012, Pages 1311-1323

  Ziegelhoffer A ^a   Mujkosova J ^a   Ferko, M ^a   Vrbjar, N ^a   Ravingerova T ^a   Ulicna O ^b   Waczulikova I ^c   Ziegelhoffer B ^d  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^c Physics and Informatics   (Slovakia)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Adaptation; Bioenergetics; Captopril; Dysadaptation; Heart; Kidney; Membrane fluidity; Mitochondria; Nifedipine; Spontaneous hypertension

Indexed keywords

ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATE; CAPTOPRIL; NIFEDIPINE;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; HEART MITOCHONDRION; HEART MUSCLE; HEART RATE; HEART WEIGHT; KIDNEY MITOCHONDRION; MALE; MEMBRANE FLUIDITY; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; RESPIRATION CONTROL; SYSTOLIC BLOOD PRESSURE;

ADAPTATION, PHYSIOLOGICAL; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAPTOPRIL; DRUG THERAPY, COMBINATION; HEART RATE; HYPERTENSION; KIDNEY; MALE; MEMBRANE FLUIDITY; MITOCHONDRIA; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANES; MYOCARDIUM; NIFEDIPINE; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 84865415385     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y2012-107     Document Type: Article

References (49)

1. Bernátová, I., Conde, N.V., Kopincová, J., González, M.C., Puzserová, A., and Arribas, S.M. 2009. Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects. J. Hypertens. 27(Suppl. 6): S27-S31. doi:10.1097/01. hjh.0000358834.18311.fc. PMID:19633448.
2. Das, A.M., and Harris, D.A. 1992. Mitochondrial ATP synthase regulation in heart: defects in hypertension are restored after treatment with captopril. Cardioscience, 3(4): 227-232. PMID: 1282376.
3. de Cavanagh, E.M., Piotrkowski, B., Basso, N, Stella, I., Inserra, F., Ferder, L., and Fraga, C.G. 2003. Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J. 17(9): 1096-1098. PMID:12709417.
4. Ferko, M., Gvozdjaková, A., Kucharská, J., Mujkosová, J., Waczulíková, I., Styk, J., et al. 2006a. Functional remodeling of heart mitochondria in acute diabetes: interrelationship between damage, endogenous protection and adaptation. Gen. Physiol. Biophys. 25(4): 397-413. PMID:17356232.
5. Ferko, M., Habodászová, D., Waczulíková, I., Mujkošová, J., Kucharská, J., Šikurová, L., and Ziegelhöffer, A. 2006b. Changes associated with functional remodeling of mitochondrial membranes in acute diabetic heart: Presence of endogenous protective mechanisms. In Potential therapeutic targets in cardiovascular and other diseases. Edited by N. Tribulová and Ľ. Okruhlicová. VEDA, Publishing House of the Slovak Academy of Sciences, Bratislava, Slovakia. pp. 8-10.
6. Ferko, M., Habodászová, D., Waczulíková, I., Mujkošová, J., Kucharská, J., Šikurová, L., et al. 2008. Endogenous protective mechanisms in remodeling of rat heart mitochondrial membranes in the acute phase of streptozotocin-induced diabetes. Physiol. Res. 57(Suppl. 2): S67-S73. PMID:18373390.
7. Fox, B.D., Shimony, A., and Langleben, D. 2011. Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension. Am. J. Cardiol. 108(8): 1177-1182. doi:10.1016/j. amjcard.2011.06.021. PMID:21864815.
8. ILAR (Institute of Laboratory Animal Resources). 1996. Guide for the Care and Use of Laboratory Animals. NIH Publication No. 85-23 (revised 1996). National Academy Press, Washington, D.C Available from www.nap.edu/openbook.php?record_id=5140.
9. Kogure, K., Watson, B.D., Busto, R., and Abe, K. 1982. Potentiation of lipid peroxides by ischemia in rat brain. Neurochem. Res. 7(4): 437-454. doi:10.1007/BF00965496. PMID:7110510.
10. Kuneš, J., and Zicha, J. 2006. Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view. Clin. Sci. 111(5): 295-305. doi:10.1042/CS20050271. PMID:17034366.
11. Kyselovič, J. 2005. Pharmacological intervention of cardiac hypertrophy induced by hypertension. In Experimental hypertension and ischemic heart disease. Edited by L. Bachárová, J. Kyselovič and J. Slezák. VEDA, Publishing House of the Slovak Academy of Sciences, Bratislava, Slovakia. pp. 117-127.
12. Lehman, J.J., and Kelly, D.P 2002. Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart. Clin. Exp. Pharmacol. Physiol. 29(4): 339-345. doi:10.1046/j.1440-1681.2002.03655.x. PMID:11985547.
13. Lowry, O.H., Rosebrough, N.J., Farr, A.I., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193(1): 265-275. PMID:14907713.
14. Máleková, L., Komínková, V, Ferko, M., Štefánik, P., Križanová, O., Ziegelhöffer, A., et al. 2007. Bongkrekic acid and atractyloside inhibits chloride channels of rat heart. Biochim. Biophys. Acta, 1767: 31-44. doi:10.1016/j.bbabio.2006.10.004. PMID: 17123460.
15. Meyers, R.S., and Siu, A. 2011. Pharmacotherapy review of chronic pediatric hypertension. Clin. Ther. 33(10): 1331-1356. doi:10. 1016/j.clinthera.2011.09.003. PMID:21982385.
16. Millgård, J., Hägg, J., Sarabi, M., and Lind, L.J. 1998. Captopril, but not nifedipine, improves endothelial-dependent vasodilation in hypertensive patients. J. Hum. Hypertens. 12(8): 511-516. doi:10. 1038/sj.jhh.1000665. PMID:9759984.
17. 2+-ATPase activity and conjugated dienes in hearts of control and acute diabetic rats: seasonal variations. In Potential therapeutic targets in cardiovascular and other diseases. Edited by N. Tribulová and Ľ.Okruhlicová. VEDA, Publishing House of the Slovak Academy of Sciences, Bratislava, Slovakia. pp. 11-13.
18. 2+-ATPase activity, conjugated dienes and membrane fluidity. Physiol. Res. 57(Suppl. 2): S75-S82. PMID:18373389.
19. Mujkošová, J., Uličná, O., Waczulíková, I., Vlkovičová, J., Vančová, O., Ferko, M., et al. 2010. Mitochondrial function in heart and kidney of spontaneously hypertensive rats: influence of captopril treatment. Gen. Physiol. Biophys. 29(2): 203-207. doi:10.4149/gpb_2010_02_203. PMID:20577032.
20. Pechánová, O. 2005. Antioxidant treatment in the experimental hypertension. In Experimental hypertension and ischemic heart disease. Edited by L. Bachárová, J. Kyselovič and J. Slezák. VEDA, Publishing House of the Slovak Academy of Sciences, Bratislava, Slovakia. pp. 131-145. doi:19633449.
21. Pechánová, O., and Šimko, F 2009. Chronic antioxidant therapy fails to emeliorate hypertension: potential mechanisms behind. J. Hypertens. 27(Suppl. 6): S27-S32. doi:10.1097/01.hjh. 0000358835.25934.5e.
22. Postnov, Y.V, Orlov, S.N., Budnikov, Y.Y., Doroschuk, A.D., and Postnov, A.Y. 2007. Mitochondrial energy conversion disturbance with decrease in ATP production as source of systemic arterial hypertension. Pathophysiology, 14(3-4): 195-204. doi:10.1016/j. pathophys.2007.09.002. PMID:17949954.
23. Ravingerová, T. 2005. Adaptive responses of the heart: a novel approach to myocardial protection. In Experimental hypertension and ischemic heart disease. Edited by L. Bachárová, J. Kyselovič and J. Slezák. VEDA, Publishing House of the Slovak Academy of Sciences, Bratislava, Slovakia. pp. 161-173.
24. Ravingerová, T., Štetka, R., Barancík, M., Volkovová, K, Pancza, D., Ziegelhöffer, A., et al. 2001. Response to ischemia and endogenous myocardial protection in the diabetic heart. In Diabetes and cardiovascular disease: from molecular processes to health policy. Edited by A. Angel, N.S. Dhalla, G.N. Pierce, PK. Singal. Adv Exp Med Biol. 498: 285-293. Kluwer Academic Plenum Publishers, New York, N.Y. PMID:11900381.
25. Reiter, R.J., Tan, D.-X., and Korkmaz, A. 2009. The circadian melatonin rhythm and its modulation: possible impact on hypertension. J. Hypertens. 27(Suppl. 6): S17-S20. doi:10.1097/ 01.hjh.0000358832.41181.bf. PMID:19633446.
26. Ritchie, R.H., and Delbridge, L.M.D. 2006. Cardiac hypertrophy, substrate utilization and metabolic remodelling: cause or effect? Clin. Exp. Pharmacol. Physiol. 33(1-2): 159-166. doi:10.1111/j. 1440-1681.2006.04342.x. PMID:16445716.
27. Roman, M.J., Saba, P.S., Pini, R., Spitzer, M., Pickering, T.G., Rosen, S., et al. 1992. Parallel cardiac and vascular adaptation in hypertension. Circulation, 86(6): 1909-1918. doi:10.1161/01. CIR.86.6.1909. PMID:1451262.
28. Rydén, L., Waeber, B., Ruilope, L.M., Mancia, G, Volpe, M., Holzgreve, H., et al. 2008. The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements. Blood Press. 17(5-6): 250-259. doi: 10.1080/ 08037050802513387. PMID:19012063.
29. Seppet, E., Gizatullina, Z., Trumbeckeite, S., Zierz, S., Striggow, E., and Gellerich, F.N. 2007. Mitochondrial medicine: The Central role of cellular energetic depression and mitochondria in cell pathophysiology. In Molecular system bioenergetics: energy for life. Edited by V Saks. Wiley WCH Verlag GmBH & Co. KGmA, Weinheim, Germany. pp. 475-520.
30. Shinitzky, M. 1984. Membrane fluidity and cellular functions. In Physiology of membrane fluidity. Edited by M. Shinitzky. CRC Press, Boca Raton, Fla. pp. 1-184.
31. Šikurová, L., Mateasík, A., and Ruttkay-Nedecký, G. 1998. Receptor destroying enzyme disturbs erythrocyte membrane ordering. Pharmazie, 53(10): 726-727. PMID:9812341.
32. Šimko, F., and Pechánová, O. 2009. Recent trends in hypertension treatment: perspectives from animal studies. J. Hypertens. 27(Suppl. 6): S1-S4. doi:10.1097/01.hjh.0000358829.87815.d4. PMID: 19633444.
33. Šimko, F., Pechánová, O., Pelouch, V., Krajčirovičová, K., Müller-ová, M., Bednárová, K., et al. 2009. Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodellíng in spontaneously hypertensive rats. J. Hypertens. 27(Suppl. 6): S5-S10. doi:10.1097/01.hjh. 0000358830.95439.e8. PMID:19633453.
34. Taussky, H.H., and Shorr, E. 1953. A microcolorimetric method for determination of inorganic phosphorus. J. Biol. Chem. 202(2): 675-685. PMID:13061491.
35. Török, J. 2005. Vascular nitric oxide and manifestation of its defficiency in conduit arteries. In Experimental hypertension and ischemic heart disease. Edited by L. Bachárová, J. Kyselovič, and J. Slezák. VEDA, Publishing House of the Slovak Academy of Sciences, Bratislava, Slovakia. pp. 81-96.
36. Uličná, O., Cízová, M., Kolesár, P., Volkovová, K., Cibulová, L., Cársky, J., and Ondrejka, P. 1997. Bioenergetika pecenových mitochondrií pri experimentálnom diabetes mellitus po podávaní ramiprilu [Bioenergetics of liver mitochondria in experimental diabetes mellitus after the administration of ramipril]. Bratisl. Lek Listy (Tlacene Vyd), 98(12): 687-694. PMID:9525068.
37. van Bilsen, M., van der Vusse, G.J., and Reneman, R.S. 1998. Transcriptional regulation of metabolic processes: implications for cardiac metabolism. Pflugers Arch. 437(1): 2-14. doi:10.1007/s004240050739. PMID:9817779.
38. Waczulíková, I., and Šikurová, L. 2010. Alterations in membrane structure and dynamics of blood elements and cadiomyocytes in diabetes. In Molecular mechanisms of diabetic complications. Edited by M. Štefek. Transworld Research Network 37/661 (2), Fort P.O. Trivandrum-695 023, Kerala, India. pp. 109-128.
39. Waczulíková, I., Šikurová, L., Cársky, J., Štrbová, L., and Krahulec, B. 2000. Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine. Gen. Physiol. Biophys. 19(4): 381-392. PMID: 11409841.
40. Waczulíková, I., Habodászová, D., Cagalinec, M., Ferko, M., Uličná, O., Mateasík, A., et al. 2007. Mitochondrial membrane fluidity, potential, and calcium transients in the myocardium from acute diabetic rats. Can. J. Physiol. Pharmacol. 85(3-4): 372-381. doi:10.1139/Y07-035. PMID:17612646.
41. Wald, D.S., Law, M., Morris, J.K., Bestwick, J.P., and Wald, N.J. 2009. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am. J. Med. 122(3): 290-300. doi:10.1016/j.amjmed.2008.09.038. PMID:19272490.
42. Zeman, M., Szántóová, K., Stebelová, K., Mravec, B., and Herichová, I. 2009. Effect of rhythmic melatonin administration on clock gene expression in the suprachiasmatic nucleus and the heart of hypertensive TGR(mRen2)27 rats. J. Hypertens. 27(Suppl. 6): S21-S26. doi:10.1097/01.hjh.0000358833.41181.f6. PMID: 19633447.
43. Zhang, G.X., Kimura, S., Nishiyama, A., Shokoji, T., Rahman, M., and Abe, Y. 2004. ROS during ther acute phase of Ang II hypertension participates in cardiovascular MAPK activation, but not vasoconstriction. Hypertension, 43(1): 117-124. doi:10.1161/ 01.HYP.0000105110.12667.F8. PMID:14638624.
44. Ziegelhöffer, A. 2005. Endogenous protective mechanisms in the heart triggered by acute streptozotocin diabetes. In Experimental hypertension and ischemic heart disease. Edited by L. Bachárová, J. Kyselovič, and J. Slezák. VEDA, Publishing House of the Slovak Academy of Sciences, Bratislava, Slovakia. pp. 193-208-96.
45. Ziegelhöffer, A., Vrbjar, N, Styk, J., Breier, A., Džurba, A., and Ravingerová, T. 1995. Adaptation of the heart to ischemia by preconditioning: effects on energy equilibrium, properties of sarcolemmal ATPases and release of cardioprotective proteins. Mol. Cell. Biochem. 147(1-2): 129-137. doi:10.1007/ BF00944793. PMID:7494541.
46. Ziegelhöffer, A., Ravingerová, T., Styk, J., Šeboková, J., Waczulíková, I., Breier, A., et al. 1997. Mechanisms that may be involved in calcium tolerance of the diabetic heart. Mol. Cell. Biochem. 176(1-2): 191-198. doi:10.1023/A:1006820224307. PMID:9406161.
47. Ziegelhöffer, A., Ravingerová, T., Waczulíková, I., Cársky, J., Neckáf, J., Ziegelhöffer-Mihalovičová, B., and Styk, J. 2002. Energy transfer in acute diabetic rat hearts. Adaptation to increased energy demands due to augmented calcium transients. Ann. N. Y Acad. Sci. 967: 1-7. doi:10.1111/j.1749-6632.2002.tb04303.x. PMID: 12079875.
48. Ziegelhöffer, A., Waczulíková, I., Ferko, M., Kincelová, D., Ziegelhöffer, B., Ravingerová, T., et al. 2009. Calcium signaling-mediated endogenous protection of cell energetics in the acutely diabetic myocardium. Can. J. Physiol. Pharmacol. 87(12): 1083-1094. doi:10.1139/Y09-108. PMID:20029545.
49. Ziegelhöffer-Mihalovičová, B., Waczulíková, I., Šikurová, L., Styk, J., Cársky, J., and Ziegelhöffer, A. 2003. Remodeling of the sarcolemma in diabetic rat hearts: the role of membrane fluidity. Mol. Cell. Biochem. 249(1-2): 175-182. doi:10.1023/A:1024703226034. PMID:12956413.